These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Pharmacochaperoning in a Asjad HMM; Kasture A; El-Kasaby A; Sackel M; Hummel T; Freissmuth M; Sucic S J Biol Chem; 2017 Nov; 292(47):19250-19265. PubMed ID: 28972153 [TBL] [Abstract][Full Text] [Related]
48. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Rojas P; Ruiz-Sánchez E; Rojas C; Ogren SO Neuroscience; 2012 Oct; 223():246-57. PubMed ID: 22885234 [TBL] [Abstract][Full Text] [Related]
49. Involvement of estrogen receptors in the resveratrol-mediated increase in dopamine transporter in human dopaminergic neurons and in striatum of female mice. Di Liberto V; Mäkelä J; Korhonen L; Olivieri M; Tselykh T; Mälkiä A; Do Thi H; Belluardo N; Lindholm D; Mudò G Neuropharmacology; 2012 Feb; 62(2):1011-8. PubMed ID: 22041555 [TBL] [Abstract][Full Text] [Related]
50. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. Wang J; Michelhaugh SK; Bannon MJ Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486 [TBL] [Abstract][Full Text] [Related]
51. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts. Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250 [TBL] [Abstract][Full Text] [Related]
52. Embryonic stem cells with GFP knocked into the dopamine transporter yield purified dopamine neurons in vitro and from knock-in mice. Zhou W; Lee YM; Guy VC; Freed CR Stem Cells; 2009 Dec; 27(12):2952-61. PubMed ID: 19750538 [TBL] [Abstract][Full Text] [Related]
53. The dopamine transporter is differentially regulated after dopaminergic lesion. Afonso-Oramas D; Cruz-Muros I; Barroso-Chinea P; Álvarez de la Rosa D; Castro-Hernández J; Salas-Hernández J; Giráldez T; González-Hernández T Neurobiol Dis; 2010 Dec; 40(3):518-30. PubMed ID: 20688165 [TBL] [Abstract][Full Text] [Related]
54. The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. Mackie P; Lebowitz J; Saadatpour L; Nickoloff E; Gaskill P; Khoshbouei H Brain Behav Immun; 2018 May; 70():21-35. PubMed ID: 29551693 [TBL] [Abstract][Full Text] [Related]
55. A vital role for voltage-dependent potassium channels in dopamine transporter-mediated 6-hydroxydopamine neurotoxicity. Redman PT; Jefferson BS; Ziegler CB; Mortensen OV; Torres GE; Levitan ES; Aizenman E Neuroscience; 2006 Nov; 143(1):1-6. PubMed ID: 17027171 [TBL] [Abstract][Full Text] [Related]
56. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972 [TBL] [Abstract][Full Text] [Related]
57. Relationship between sensorimotor gating deficits and dopaminergic neuroanatomy in Nurr1-deficient mice. Vuillermot S; Feldon J; Meyer U Exp Neurol; 2011 Nov; 232(1):22-32. PubMed ID: 21820432 [TBL] [Abstract][Full Text] [Related]
58. Mutations in the Parkinson's Disease-Associated PARK2 Gene Are Accompanied by Imbalance in Programmed Cell Death Systems. Konovalova EV; Lopacheva OM; Grivennikov IA; Lebedeva OS; Dashinimaev EB; Khaspekov LG; Fedotova EY; Illarioshkin SN Acta Naturae; 2015; 7(4):146-9. PubMed ID: 26798503 [TBL] [Abstract][Full Text] [Related]
59. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Goldberg MS; Pisani A; Haburcak M; Vortherms TA; Kitada T; Costa C; Tong Y; Martella G; Tscherter A; Martins A; Bernardi G; Roth BL; Pothos EN; Calabresi P; Shen J Neuron; 2005 Feb; 45(4):489-96. PubMed ID: 15721235 [TBL] [Abstract][Full Text] [Related]
60. Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum. Singh S; Singh K; Gupta SP; Patel DK; Singh VK; Singh RK; Singh MP Brain Res; 2009 Aug; 1283():115-26. PubMed ID: 19520064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]